Gregoire Vuagniaux

Dr. Gregoire Vuagniaux


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 March 2013 in Viruses
Verified
Journal Article
Open access
PDF file
Philippe GallayPhilippe Gallay
Philippe Gallay
RPRoger G. Ptak
Roger G. Ptak
MBMichael Bobardt
Michael Bobardt
JDJean-Maurice Dumont
Jean-Maurice Dumont
GVGregoire Vuagniaux
Gregoire Vuagniaux
BRBrigitte Rosenwirth
Brigitte Rosenwirth
DEB025 (alisporivir) is a synthetic cyclosporine with inhibitory activity against human immunodeficiency virus type-1 (HIV-1) and hepatitis C virus (HCV). It binds to cyclophilin A (CypA) and blocks essential functions of CypA in the viral replication cycles of both viruses. DEB025 inhibits clinical HIV-1 isolates in vitro and decreases HIV-1 virus load in the majority of patients. HIV-1 isolates being naturally resistant to DEB025 have been detected in vitro and in nonresponder patients. By sequence analysis of their capsid protein (CA) region, two amino acid polymorphisms that correlated with DEB025 resistance were identified: H87Q and I91N, both located in the CypA-binding loop of the CA protein of HIV-1. The H87Q change was by far more abundant than I91N. Additional polymorphisms in the CypA-binding loop (positions 86, 91 and 96), as well as in the N-terminal loop of CA were detected in resistant isolates and are assumed to contribute to the degree of resistance. These amino acid changes may modulate the conformation of the CypA-binding loop of CA in such a way that binding and/or isomerase function of CypA are no longer necessary for virus replication. The resistant HIV-1 isolates thus are CypA-independent.

8 October 2010 in Respiratory Research
Verified
Journal Article
Open access
PDF file
VEvirginie Escabasse
virginie Escabasse
CCChristine Clerici
Christine Clerici
GVGregoire Vuagniaux
Gregoire Vuagniaux
ACAndre Coste
Andre Coste
EEEstelle Escudier
Estelle Escudier
CPCarole Planès
Carole Planès
Hyperactivity of the epithelial sodium (Na+) channel (ENaC) and increased Na+ absorption by airway epithelial cells leading to airway surface liquid dehydration and impaired mucociliary clearance are thought to play an important role in the pathogenesis of cystic fibrosis (CF) pulmonary disease. In airway epithelial cells, ENaC is constitutively activated by endogenous trypsin-like serine proteases such as Channel-Activating Proteases (CAPs). It was recently reported that ENaC activity could also be stimulated by apical treatment with human neutrophil elastase (hNE) in a human airway epithelial cell line, suggesting that hNE inhibition could represent a novel therapeutic approach for CF lung disease. However, whether hNE can also activate Na+ reabsorption in primary human nasal epithelial cells (HNEC) from control or CF patients is currently unknown.

4 May 2009 in Antiviral Research
Verified
Journal Article
Closed access
LCLotte Coelmont
Lotte Coelmont
PGPhilippe Gallay
Philippe Gallay
MBMichael Bobardt
Michael Bobardt
SKSuzanne Kaptein
Suzanne Kaptein
JPJan Paeshuyse
Jan Paeshuyse
JNJohan Hendrik Neyts
Johan Hendrik Neyts